External validity of randomized controlled trials in older adults, a systematic review

Abstract

BackgroundTo critically assess the external validity of randomized controlled trials (RCTs) it is important to know what older adults have been enrolled in the trials. The aim of this systematic review is to study what proportion of trials specifically designed for older patients report on somatic status, physical and mental functioning, social environment and frailty in the patient characteristics.MethodsPubMed was searched for articles published in 2012 and only RCTs were included. Articles were further excluded if not conducted with humans or only secondary analyses were reported. A random sample of 10% was drawn. The current review analyzed this random sample and further selected trials when the reported mean age was ≥ 60 years. We extracted geriatric assessments from the population descriptives or the in- and exclusion criteria.ResultsIn total 1396 trials were analyzed and 300 trials included. The median of the reported mean age was 66 (IQR 63–70) and the median percentage of men in the trials was 60 (IQR 45–72). In 34% of the RCTs specifically designed for older patients somatic status, physical and mental functioning, social environment or frailty were reported in the population descriptives or the in- and exclusion criteria. Physical and mental functioning was reported most frequently (22% and 14%). When selecting RCTs on a mean age of 70 or 80 years the report of geriatric assessments in the patient characteristics was 46% and 85% respectively but represent only 5% and 1% of the trials.ConclusionSomatic status, physical and mental functioning, social environment and frailty are underreported even in RCTs specifically designed for older patients published in 2012. Therefore, it is unclear for clinicians to which older patients the results can be applied. We recommend systematic to transparently report these relevant characteristics of older participants included in RCTs.

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data

“…Because of this strict patient selection in RCTs, the patient population may differ in daily clinical practice. Thus, treatment effect in clinical practice may be different from an RCT‐based treatment effect …”

“…Thus, treatment effect in clinical practice may be different from an RCT-based treatment effect. 3,5,6 Observational studies without patient selection, although lower on the GRADE scale, are closer to clinical practice. In particular, after the introduction of electronic medical records, more and more scientists and decision makers are arguing for the use of observational studies in addition to RCTs.…”

Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines

“…Although clinically relevant, the subject of statin discontinuation in older adults gets little attention in current international cardiovascular prevention guidelines, resulting in a lack of clear guidance for physicians reconsidering statin treatment in older adults with complex health problems. In this population, physicians will have to decide to continue or discontinue statins based on personal judgment, since evidence concerning the optimal duration of statin treatment in older frail adults or adults with multimorbidity is currently lacking . Grants to develop randomized trials on deprescribing in older adults will probably result in more evidence for deprescribing.…”

Geriatric emergency medicine: time for a new approach on a European level

“…But evidence on how to treat older patients is lacking, as older patients are often excluded from clinical studies and specific frailty syndromes are not reported, even in trials designed specifically for this patient group. [4,5].…”